Amplia Therapeutics Limited (ASX: $ATX) has requested a trading halt for up to 2 days to undertake an entitlement offer process. The company expects normal trading to resume on Tuesday, 16 April 2024, upon releasing an announcement regarding the capital raising.
The company has requested the trading halt to facilitate the entitlement offer process. We anticipate that this will allow us to effectively manage the capital raising and ensure a smooth transition back to normal trading once the announcement is released. We are committed to keeping the market informed and look forward to providing further details in the upcoming announcement.
Amplia Therapeutics Limited (ASX: $ATX) has requested a trading halt to facilitate an entitlement offer process. The company aims to resume normal trading on Tuesday, 16 April 2024, upon releasing an announcement regarding the capital raising. This trading halt aligns with the company's commitment to transparent communication and effective management of capital raising activities. Investors can anticipate further details upon the release of the market announcement.